In recent years, extensive reports have demonstrated the tumour suppressing roles of HADHB in various cancers, such as colorectal cancer (CRC), oral squamous cell carcinoma (OSCC), and acute myeloid leukaemia (AML) (15–17). Here, HADHB is linked to cancer.